The distance hierarchy of PD-L1 gain over PD-1 is: patient 4 > 3 > 2 > 5 > 1 for the melanoma treatment group, where patient 6 is the exception in which PD-1 ended with a higher expression gain than PD-L1. Here, CD274 is linked to melanoma.